Effects of postoperative treatment with chemotherapy and cellular immunotherapy on patients with colorectal cancer

Table 1 Baseline data of the colorectal cancer cohort included in this study

Baseline data	Control group (n = 55)	Research group (n = 66)	χ2/t	P value
Age (years), mean ± SD	57.09 ± 7.75	56.41 ± 11.14	0.382	0.703
Sex, n (%)			0.111	0.740
Male	30 (54.55)	34 (51.52)
Female	25 (45.45)	32 (48.48)
Onset site, n (%)			0.186	0.666
Colon	27 (49.09)	35 (53.03)
Rectum	28 (50.91)	31 (46.97)
Pathological type, n (%)			0.043	0.836
Adenocarcinoma	49 (89.09)	58 (87.88)
Other	6 (10.91)	8 (12.12)
Clinical stage, n (%)			0.029	0.864
II	35 (63.64)	41 (62.12)
III	20 (36.36)	25 (37.88)
Differentiation, n (%)			0.021	0.885
Moderately- or well-differentiated	39 (70.91)	46 (69.70)
Poorly differentiated	16 (29.09)	20 (30.30)